Literature DB >> 19443732

Epithelial cells in fetal intestine produce chemerin to recruit macrophages.

Akhil Maheshwari1, Ashish R Kurundkar, Sadiq S Shaik, David R Kelly, Yolanda Hartman, Wei Zhang, Reed Dimmitt, Shehzad Saeed, David A Randolph, Charles Aprahamian, Geeta Datta, Robin K Ohls.   

Abstract

Macrophages are first seen in the fetal intestine at 11-12 wk and rapidly increase in number during the 12- to 22-wk period of gestation. The development of macrophage populations in the fetal intestine precedes the appearance of lymphocytes and neutrophils and does not require the presence of dietary or microbial antigens. In this study, we investigated the role of chemerin, a recently discovered, relatively selective chemoattractant for macrophages, in the recruitment of macrophage precursors to the fetal intestine. Chemerin mRNA/protein expression was measured in jejunoileal tissue from 10- to 24-wk human fetuses, neonates operated for intestinal obstruction, and adults undergoing bariatric surgery. The expression of chemerin in intestinal epithelial cells (IECs) was confirmed by using cultured primary IECs and IEC-like cell lines in vitro. The regulatory mechanisms involved in chemerin expression were investigated by in silico and immunolocalization techniques. IECs in the fetal, but not mature, intestine express chemerin. Chemerin expression peaked in the fetal intestine at 20-24 wk and then decreased to original low levels by full term. During the 10- to 24-wk period, chemerin accounted for most of the macrophage chemotactic activity of cultured fetal IECs. The maturational changes in chemerin expression correlated with the expression of retinoic acid receptor-beta in the intestine. Chemerin is an important mediator of epithelial-macrophage cross talk in the fetal/premature, but not in the mature, intestine. Understanding the regulation of the gut macrophage pool is an important step in development of novel strategies to boost mucosal immunity in premature infants and other patient populations at risk of microbial translocation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443732      PMCID: PMC2711762          DOI: 10.1152/ajpgi.90730.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  67 in total

Review 1.  Role of N-glycosylation in trafficking of apical membrane proteins in epithelia.

Authors:  Olga Vagin; Jeffrey A Kraut; George Sachs
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-29

2.  Isolation and purification of human intestinal macrophages.

Authors:  Lesley E Smythies; Larry M Wahl; Philip D Smith
Journal:  Curr Protoc Immunol       Date:  2006-01

3.  Using TESS to predict transcription factor binding sites in DNA sequence.

Authors:  Jonathan Schug
Journal:  Curr Protoc Bioinformatics       Date:  2008-03

4.  Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque.

Authors:  D English; B R Andersen
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

5.  Chemerin--a new adipokine that modulates adipogenesis via its own receptor.

Authors:  Sang-gun Roh; Sang-Houn Song; Ki-Choon Choi; Kazuo Katoh; Valérie Wittamer; Marc Parmentier; Shin-ichi Sasaki
Journal:  Biochem Biophys Res Commun       Date:  2007-08-27       Impact factor: 3.575

6.  Developmental changes in circulating IL-8/CXCL8 isoforms in neonates.

Authors:  Akhil Maheshwari; Nikolai N Voitenok; Svetlana Akalovich; Sadiq S Shaik; David A Randolph; Brian Sims; Rakesh P Patel; Cheryl R Killingsworth; Michael B Fallon; Robin K Ohls
Journal:  Cytokine       Date:  2009-02-15       Impact factor: 3.861

Review 7.  Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages.

Authors:  B Kelsall
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

8.  Chemerin is a novel adipokine associated with obesity and metabolic syndrome.

Authors:  Kiymet Bozaoglu; Kristy Bolton; Janine McMillan; Paul Zimmet; Jeremy Jowett; Greg Collier; Ken Walder; David Segal
Journal:  Endocrinology       Date:  2007-07-19       Impact factor: 4.736

9.  The distribution, ontogeny and origin in the rat of Ia-positive cells with dendritic morphology and of Ia antigen in epithelia, with special reference to the intestine.

Authors:  G Mayrhofer; C W Pugh; A N Barclay
Journal:  Eur J Immunol       Date:  1983-02       Impact factor: 5.532

10.  Synthetic chemerin-derived peptides suppress inflammation through ChemR23.

Authors:  Jenna L Cash; Rosie Hart; Andreas Russ; John P C Dixon; William H Colledge; Joanne Doran; Alan G Hendrick; Mark B L Carlton; David R Greaves
Journal:  J Exp Med       Date:  2008-04-07       Impact factor: 14.307

View more
  27 in total

1.  Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis.

Authors:  Andrew A Maynard; Katerina Dvorak; Ludmila Khailova; Holly Dobrenen; Kelly M Arganbright; Melissa D Halpern; Ashish R Kurundkar; Akhil Maheshwari; Bohuslav Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-10       Impact factor: 4.052

2.  Chemerin/ChemR23 signaling axis is involved in the endothelial protection by K(ATP) channel opener iptakalim.

Authors:  Rui-jun Zhao; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

3.  Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model.

Authors:  Krishnan MohanKumar; Niroop Kaza; Ramasamy Jagadeeswaran; Steven A Garzon; Anchal Bansal; Ashish R Kurundkar; Kopperuncholan Namachivayam; Juan I Remon; C Rekha Bandepalli; Xu Feng; Joern-Hendrik Weitkamp; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-26       Impact factor: 4.052

4.  TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine.

Authors:  Akhil Maheshwari; David R Kelly; Teodora Nicola; Namasivayam Ambalavanan; Sunil K Jain; Joanne Murphy-Ullrich; Mohammad Athar; Masako Shimamura; Vineet Bhandari; Charles Aprahamian; Reed A Dimmitt; Rosa Serra; Robin K Ohls
Journal:  Gastroenterology       Date:  2010-09-24       Impact factor: 22.682

5.  Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet.

Authors:  Ashish R Kurundkar; Cheryl R Killingsworth; R Britt McIlwain; Joseph G Timpa; Yolanda E Hartman; Dongning He; Rajendra K Karnatak; Mary L Neel; John P Clancy; G M Anantharamaiah; Akhil Maheshwari
Journal:  Pediatr Res       Date:  2010-08       Impact factor: 3.756

Review 6.  Chemerin, a novel player in inflammatory bowel disease.

Authors:  C Buechler
Journal:  Cell Mol Immunol       Date:  2014-04-07       Impact factor: 11.530

7.  Chemerin-ChemR23 signaling in tooth development.

Authors:  T Ohira; D Spear; N Azimi; V Andreeva; P C Yelick
Journal:  J Dent Res       Date:  2012-10-09       Impact factor: 6.116

8.  M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.

Authors:  Jia Wei; Gail E Besner
Journal:  J Surg Res       Date:  2015-03-18       Impact factor: 2.192

Review 9.  Immunologic and Hematological Abnormalities in Necrotizing Enterocolitis.

Authors:  Akhil Maheshwari
Journal:  Clin Perinatol       Date:  2015-05-13       Impact factor: 3.430

10.  Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.

Authors:  R Britt McILwain; Joseph G Timpa; Ashish R Kurundkar; David W Holt; David R Kelly; Yolanda E Hartman; Mary Lauren Neel; Rajendra K Karnatak; Robert L Schelonka; G M Anantharamaiah; Cheryl R Killingsworth; Akhil Maheshwari
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.